MedTrace Logo

The Postprandial Calcium Absorption of a Milk Derived Calcium Permeate - RENEW Acute Study

NCT04550078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-11-17

No results posted yet for this study

Summary

This is a randomized controlled cross-over meal study with the overall aim to investigate the postprandial calcium absorption from calcium permeate compared with calcium carbonate. The hypothesis is that the bioavailability of calcium permeate is equal to or higher than calcium carbonate. This will be investigated in a cross-over design with 10 postmenopausal women age 50-65 as subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Calcium Carbonate

Subjects receive a single-dose of 800 mg calcium as calcium carbonate provided in 6 capsules with a standardized breakfast served in the morning.

DIETARY_SUPPLEMENT

Calcium Permeate

Subjects receive a single-dose of 800 mg milk calcium as calcium permeate provided in 6 capsules with a standardized breakfast served in the morning.

DIETARY_SUPPLEMENT

Placebo

Subjects receive a single-dose of 0 mg calcium as placebo with maltodextrin provided in 6 capsules with a standardized breakfast served in the morning.

Sponsors & Collaborators

  • Zealand University Hospital

    collaborator OTHER

  • Arla Foods

    collaborator INDUSTRY

  • University of Aarhus

    collaborator OTHER

  • Innovation Fund Denmark

    collaborator INDIV

  • Inge Tetens

    lead OTHER

Principal Investigators

  • Inge Tetens, Professor · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2020-11-06
Completion
2020-11-06

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550078 on ClinicalTrials.gov